You are here: Home » News-IANS » Health-Medicine
Business Standard

New treatment for diabetic kids shows promise

IANS  |  New York 

A new treatment for Type-2 in children has shown promise in a clinical trial, according to a study.

The drug, liraglutide, in combination with an existing medication, metformin, showed a robust effect in treating children with Type-2 diabetes, the results showed.

"This adult medication was very effective in our trial of youth with Type-2 and was well tolerated," said Jane Lynch, at at San Antonio in the US.

Currently only two drugs, metformin and insulin, are approved for the treatment of Type 2 diabetes in children in the US.

"We urgently need other options for medical treatment of Type-2 diabetes in our youth under age 18. If approved, this drug would be a fantastic new option to complement oral metformin therapy as an alternative to insulin for our youth and adolescents with Type 2 diabetes," said Lynch.

The study compared outcomes of 66 children who received liraglutide shots plus metformin pills for 26 weeks with the outcomes of 68 other children who received metformin and a placebo. Children between ages 10 and 17 were eligible for the study.

The research, published in The of Medicine, was a randomised, parallel-group, placebo-controlled trial.

The average age of the participant children was 14.6 years, and more than 60 per cent were female.

--IANS

bu/gb/bc

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Tue, April 30 2019. 13:00 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU